Hi-Clearance
Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and RO machines, and related consumables and drugs; interventional cardiology and radiology, and vascular surgery devices; dental consumables, implant materials, and equipment; and blood glucose monitors, and related consumabl… Read more
Market Cap & Net Worth: Hi-Clearance (1788)
Hi-Clearance (TWO:1788) has a market capitalization of $184.35 Million (NT$6.10 Billion) as of March 19, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #18056 globally and #796 in its home market, demonstrating a 0.37% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hi-Clearance's stock price NT$137.00 by its total outstanding shares 44521000 (44.52 Million).
Hi-Clearance Market Cap History: 2015 to 2026
Hi-Clearance's market capitalization history from 2015 to 2026. Data shows growth from $87.15 Million to $184.35 Million (9.13% CAGR).
Hi-Clearance Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hi-Clearance's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.05x
Hi-Clearance's market cap is 0.05 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.52x
Hi-Clearance's market cap is 0.52 times its annual earnings
1.95x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $87.15 Million | $2.74 Billion | $216.89 Million | 0.03x | 0.40x |
| 2016 | $80.29 Million | $2.83 Billion | $207.56 Million | 0.03x | 0.39x |
| 2017 | $88.03 Million | $2.96 Billion | $251.08 Million | 0.03x | 0.35x |
| 2018 | $96.16 Million | $3.10 Billion | $243.45 Million | 0.03x | 0.39x |
| 2019 | $109.45 Million | $3.24 Billion | $245.74 Million | 0.03x | 0.45x |
| 2020 | $133.50 Million | $3.43 Billion | $317.29 Million | 0.04x | 0.42x |
| 2021 | $169.73 Million | $3.68 Billion | $348.59 Million | 0.05x | 0.49x |
| 2022 | $173.94 Million | $4.69 Billion | $366.43 Million | 0.04x | 0.47x |
| 2023 | $173.62 Million | $3.90 Billion | $347.98 Million | 0.04x | 0.50x |
| 2024 | $187.71 Million | $4.07 Billion | $359.69 Million | 0.05x | 0.52x |
Competitor Companies of 1788 by Market Capitalization
Companies near Hi-Clearance in the global market cap rankings as of March 19, 2026.
Key companies related to Hi-Clearance by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Hi-Clearance Historical Marketcap From 2015 to 2026
Between 2015 and today, Hi-Clearance's market cap moved from $87.15 Million to $ 184.35 Million, with a yearly change of 9.13%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$184.35 Million | +0.37% |
| 2025 | NT$183.68 Million | -2.15% |
| 2024 | NT$187.71 Million | +8.12% |
| 2023 | NT$173.62 Million | -0.19% |
| 2022 | NT$173.94 Million | +2.49% |
| 2021 | NT$169.73 Million | +27.14% |
| 2020 | NT$133.50 Million | +21.97% |
| 2019 | NT$109.45 Million | +13.82% |
| 2018 | NT$96.16 Million | +9.24% |
| 2017 | NT$88.03 Million | +9.64% |
| 2016 | NT$80.29 Million | -7.87% |
| 2015 | NT$87.15 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Hi-Clearance was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $184.35 Million USD |
| MoneyControl | $184.35 Million USD |
| MarketWatch | $184.35 Million USD |
| marketcap.company | $184.35 Million USD |
| Reuters | $184.35 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.